Because we have shown that at least some cancers [19, 20] can reproduce in their tumour micro environments the potent immune suppressive biological effects of ‘cyclosporine-like drugs’, it is possible that direct intra tumoural injections of interleukin-2 (IL-2) might locally reverse this immune suppression and reduce tumour volume [32]. Here, IL2 is linked to neoplasm.